CNSide Diagnostics

CNSide Diagnostics, LLC is a company dedicated to developing and commercializing proprietary clinical diagnostic laboratory assays.  The first-in-class CNSide® CSF assay is performed in a CLIA-registered facility in Houston, Texas at the request of top cancer physicians in the U.S.

At CNSide Diagnostics, LLC, our mission is to revolutionize the clinical management of patients with Leptomeningeal Metastases (LM) through innovative diagnostic solutions.

Our vision is to improve patient outcomes by delivering cutting-edge diagnostics that enable personalized and effective treatment strategies.